{"id":"W2743957775","doi":"10.1111/dme.13450","title":"Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase <scp>III ODYSSEY</scp> clinical trials","year":2017,"lang":"en","type":"article","venue":"Diabetic Medicine","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Regeneron Pharmaceuticals; Sanofi","keywords":"Prediabetes; Alirocumab; Medicine; PCSK9; Internal medicine; Type 2 diabetes; Population; Diabetes mellitus; Placebo; Endocrinology; Statin; Evolocumab; Cholesterol; Gastroenterology; Lipoprotein; LDL receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02030504,0.00237057,0.01119442,0.001610705,0.0003186189,0.002427415,0.0006855038,0.001388186,0.001897225],"category_scores_gemma":[0.01576161,0.001046299,0.02483844,0.0019471,0.0005034661,0.00098038,0.00110888,0.001448355,0.0002146913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007850003,"about_ca_system_score_gemma":0.00119159,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001428666,"about_ca_topic_score_gemma":0.002969334,"domain_scores_codex":[0.9858025,0.009385274,0.002368398,0.001174604,0.000980772,0.0002882865],"domain_scores_gemma":[0.9892398,0.005723402,0.00318392,0.0007363111,0.0008316532,0.000284987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.2065821,0.0001573673,0.01268632,0.02512289,0.7330877,0.0001053324,0.0000730288,0.001099376,0.001755073,0.00009296749,0.001351335,0.01788653],"study_design_scores_gemma":[0.07599079,0.008057669,0.03932527,0.00187925,0.8696705,0.0001676313,0.00007878606,0.0009913857,0.0007921894,0.0003787809,0.002595103,0.00007269278],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.3710294,0.6075311,0.005507774,0.0009149962,0.00109172,0.002877726,0.007820565,0.0002355921,0.002991065],"genre_scores_gemma":[0.936597,0.05258106,0.002558563,0.001138196,0.0004758033,0.002026127,0.003804971,0.00007474882,0.0007433977],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.02030504,"threshold_uncertainty_score":0.1073846,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03817322012029548,"score_gpt":0.3683208319892581,"score_spread":0.3301476118689627,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}